Marshall Wace, LLP Dynavax Technologies Corp Transaction History

Marshall Wace, LLP

  • $74.4 Billion
  • Q1 2025

A detailed history of Marshall Wace, LLP transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 875,858 shares of DVAX stock, worth $8.67 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
875,858
Holding current value
$8.67 Million
% of portfolio
0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$12.39 - $14.4 $10.9 Million - $12.6 Million
875,858 New
875,858 $11.4 Million
Q2 2024

Aug 14, 2024
BUY
$10.73 - $12.58 $861,619 - $1.01 Million
80,300 New
80,300 $901,000
Q4 2023

Feb 14, 2024
BUY
$13.09 - $14.98 $1 Million - $1.15 Million
76,684 Added 87.62%
164,207 $2.3 Million
Q3 2023

Nov 14, 2023
BUY
$12.64 - $14.99 $1.11 Million - $1.31 Million
87,523 New
87,523 $1.29 Million
Q3 2022

Nov 14, 2022
BUY
$9.93 - $17.44 $4.41 Million - $7.75 Million
444,132 New
444,132 $4.64 Million
Q2 2022

Aug 15, 2022
SELL
$7.45 - $12.83 $6.45 Million - $11.1 Million
-866,332 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$9.75 - $14.44 $140,760 - $208,470
14,437 Added 1.69%
866,332 $9.39 Million
Q4 2021

Feb 14, 2022
SELL
$13.17 - $20.94 $56.2 Million - $89.3 Million
-4,264,961 Reduced 83.35%
851,895 $12 Million
Q3 2021

Nov 15, 2021
BUY
$9.16 - $19.83 $46.9 Million - $101 Million
5,116,856 New
5,116,856 $98.3 Million
Q2 2021

Aug 13, 2021
SELL
$7.25 - $10.99 $2.51 Million - $3.81 Million
-346,586 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$4.57 - $11.18 $1.58 Million - $3.87 Million
346,586 New
346,586 $3.41 Million
Q2 2019

Aug 14, 2019
SELL
$3.65 - $7.89 $60,038 - $129,782
-16,449 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$7.08 - $12.09 $80,619 - $137,668
11,387 Added 224.95%
16,449 $120,000
Q4 2018

Feb 14, 2019
SELL
$8.14 - $13.28 $598,485 - $976,398
-73,524 Reduced 93.56%
5,062 $46,000
Q3 2018

Nov 14, 2018
BUY
$11.85 - $16.0 $931,244 - $1.26 Million
78,586 New
78,586 $974,000

Others Institutions Holding DVAX

# of Institutions
312
Shares Held
129M
Call Options Held
493K
Put Options Held
269K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.25B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email